Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Genetics
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Genetics. 2009;2:1-2
doi: 10.1161/CIRCGENETICS.109.850370
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borecki, I. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Borecki, I. B.
Related Collections
Right arrow Risk Factors
Right arrow Genomics
Right arrowRelated Articles

Editorials

Contemporary Approaches to Gene Discovery

Progress Toward Personalized Medicine?

Ingrid B. Borecki, PhD

From the Division of Statistical Genomics, Washington University School of Medicine, St Louis, Mo.

Correspondence to Ingrid B. Borecki, PhD, Division of Statistical Genomics, Washington University School of Medicine, 4444 Forest Park Boulevard, Box 8506, St Louis, MO 63108. E-mail: iborecki@wustl.edu

Key Words: gene discovery • GWA • predictive index • atherosclerosis • genetics


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

It is broadly recognized that cardiovascular disease has a familial basis; however, progress in identifying the causative genes has been slow. The goal of identifying disease genes or those genes influencing cardiovascular risk factor phenotypes is at the heart of personalized medicine, giving rise to the hope that such knowledge will identify new therapeutic targets, help identify individuals at high risk to receive interventional therapy, and perhaps help to refine prognosis once clinical disease is present. Testing of candidate genes and genome-wide searches using anonymous, highly polymorphic markers via linkage studies has produced some information regarding the location of putative trait genes but has left open the question of precisely which genes are at play, which are the relevant variants, and how they function to modify disease risk. The advent of high-density arrays, in which up to a million single-nucleotide polymorphisms can be assessed in thousands of subjects in a cost-effective manner, has opened the door to an unprecedented level of inquiry. Much finer mapping information can be obtained because this approach relies on linkage disequilibrium, which extends over much shorter distances than does linkage.

Articles see pp 7 and 63

There is currently vigorous activity in almost all domains of complex human diseases to apply genome-wide association scans (GWAS) to identify trait loci. In this issue of Circulation: Cardiovascular Genetics, Ding and Kullo1 review the basic tenants of this approach and the progress that has been made toward gene discovery in the area of atherosclerotic heart disease. The . . . [Full Text of this Article]


Related Articles

Genome-Wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors
Keyue Ding and Iftikhar J. Kullo
Circ Cardiovasc Genet 2009 2: 63-72. [Extract] [Full Text] [PDF]

Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers
John P.A. Ioannidis
Circ Cardiovasc Genet 2009 2: 7-15. [Abstract] [Full Text] [PDF]